Ann: Quarterly Activities Report & Appendix 4C, page-9

I didn't reference the combination arms ? My post was solely about the mono arm DEP® docetaxel trial .... you know the one that was supposed to be finished in 2018 according to JF herself ?


Like I predicted in January this year when they moved the goal posts for the FOURTH time, we won't see full readouts in 2022 but the fan club wouldn't have it ? I notice they are all very quiet after today's Quarterly has been released


I know the only winners in a Class Action are the lawyers but I have had enough the 'spin' from this mob that never comes to fruition ... @smarttogether posted that he had made initial enquiries with a lawyer but I think it is high time I made some of my own - how there is no accountability year after year after year when timelines made by the company officeholders themselves come and go repeatedly with no explanations is nonsense ?


.... and don't even get me started on all the supposed "secret partners" or "undisclosed partners" as it is termed of late that they have been working upon since 2016 while never once disclosing who they are - we are 7 years in with the carrot still being dangled in presentations to shareholders